2085

antibody from Cell Signaling Technology, Inc

Targeting: EGFR ERBB, ERBB1

Western blot (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunoprecipitation (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Antibody Data

Product number

2085

Provider

Cell Signaling Technology, Inc

Proper citation

Cell Signaling Technology Cat#2085, RRID:AB_1903953

Product name

EGF Receptor (E746-A750del Specific) (D6B6) XP® Rabbit mAb

Antibody type

Monoclonal

Reactivity

Human

Host

Rabbit

Storage

-20°C

References

Submitted references

Analysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion.

Rimkunas VM, Crosby KE, Li D, Hu Y, Kelly ME, Gu TL, Mack JS, Silver MR, Zhou X, Haack H
Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Aug 15;18(16):4449-57

---

Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR.

Brevet M, Arcila M, Ladanyi M
The Journal of molecular diagnostics : JMD 2010 Mar;12(2):169-76

---

Molecular diagnosis of activating EGFR mutations in non-small cell lung cancer using mutation-specific antibodies for immunohistochemical analysis.

Kawahara A, Yamamoto C, Nakashima K, Azuma K, Hattori S, Kashihara M, Aizawa H, Basaki Y, Kuwano M, Kage M, Mitsudomi T, Ono M
Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Jun 15;16(12):3163-70

---

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.

Simonetti S, Molina MA, Queralt C, de Aguirre I, Mayo C, Bertran-Alamillo J, Sanchez JJ, Gonzalez-Larriba JL, Jimenez U, Isla D, Moran T, Viteri S, Camps C, Garcia-Campelo R, Massuti B, Benlloch S, Ramon y Cajal S, Taron M, Rosell R
Journal of translational medicine 2010 Dec 18;8:135

---

Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer.

Yu J, Kane S, Wu J, Benedettini E, Li D, Reeves C, Innocenti G, Wetzel R, Crosby K, Becker A, Ferrante M, Cheung WC, Hong X, Chirieac LR, Sholl LM, Haack H, Smith BL, Polakiewicz RD, Tan Y, Gu TL, Loda M, Zhou X, Comb MJ
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 May 1;15(9):3023-8